semaglutide vs mounjaro weight loss vs. Wegovy: The 2026 Guide for Asian Bodies & Thai Patients - Siam Clinic Semaglutide vs. Mounjaro: A Weight

Transl Psychiatry 8, 242 (2018)

Current evidence does not suggest that GLP-1 receptor agonists have clinically significant immunosuppressive properties that would impact vaccination responses, though specific studies with influenza vaccines are limited

Recent studies have provided consistent evidence on the association of hyperuricemia with adverse outcomes, primarily with the increased risk of mortality in patients with HF

Wegovy, Ozempic and Eli Lilly's Mounjaro and Zepbound belong to a class of therapies known as GLP-1 receptor agonists originally developed to control blood sugar in patients with type 2 diabetes

They both work relatively the same way, and they both have been designed to treat HGH loss by stimulating your body to make more HGH